Spatial map of bladder cancer reveals hidden tumor environments and new paths toward precision therapy - UT MD Anderson
Spatial map of bladder cancer reveals hidden tumor environments and new paths toward precision therapy UT MD Anderson
Spatial map of bladder cancer reveals hidden tumor environments and new paths toward precision therapy UT MD Anderson
Evaluating Bladder-Sparing Strategies and Key GU Data From ASCO 2026 CancerNetwork
ADCs Continue to Transform Bladder Cancer Care Oncology News Central
UT MD Anderson Shares Latest Research Breakthroughs | Newswise Newswise
Simultaneous High-Grade Upper-Tract Urothelial Carcinoma and Xanthogranulomatous Pyelonephritis Cureus
AI and ctDNA: Advancing Precision Bladder Cancer Care Oncology Nursing News
ZUSDURI and the ENVISION Trial: A Non-Surgical Path Forward for Recurrent Bladder Cancer Cure Today
Computational AI for Predicting Grade Progression in Intermediate-Risk Bladder Cancer - Roger Li UroToday
Intravenous or Subcutaneous Atezolizumab for Bladder Cancer After Surgery American Association for Cancer Research (AACR)
10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer PR Newswire
A new sensor could enable earlier detection of bladder cancer MIT News
Relmada's Cancer Drug Candidate Sparks Fresh Bullish Call Benzinga
Gemcitabine Intravesical System: A Novel Treatment Option for BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer Pharmacy Times
Immune Biomarkers May Predict Response to Bladder Cancer Treatment Northwestern University
Perioperative SHR-A2102 Plus Adebrelimab Shows Promise for MIBC Renal and Urology News
Cost-Effectiveness of BCG plus Immune Checkpoint Inhibitors in High-Risk NMIBC - Daniel Joyce UroToday
Primary Signet-Ring Cell Adenocarcinoma of the Urinary Bladder: A Report of a Rare Case Cureus
ASCO 2026: New Approaches to Curing Bladder and Kidney Cancers: Where Do We Stand Today? UroToday
Imfinzi approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer. AstraZeneca
Manual advances robot-assisted bladder cancer surgery Buffalo News
“I’m Living Life Every Day”: A Veteran’s Message After Becoming Cancer-Free Black Doctor
Preop ctDNA May Identify Aggressive Bladder Cancer Better Than Nodal Status Renal and Urology News
Zele in Combination With Pembrolizumab Shows Promise in Bladder Cancer Oncology News Central
Does Tumor Size Influence Survival Outcomes Across Bladder Cancer Treatment Approaches? Cancer Nursing Today
2026 AACR Bladder Cancer Highlights Conexiant
10x Genomics, Cleveland Clinic study aims to predict bladder cancer treatment response Stock Titan
FDA Approves Durvalumab for Non-Muscle Invasive Bladder Cancer Oncology News Central
Doctors hail drug that spares bladder cancer patients ‘life-changing’ surgery The Guardian
Interim Results from the ADVANCED-2 Trial of TARA-002 in BCG-Unresponsive CIS Bladder Cancer - Timothy Clinton UroToday
The Most Asked Bladder Cancer Questions: Signs, Symptoms, Stages and Treatment Options Cure Today
New study looks at pesticide exposure and bladder cancer risk among Hmong farmworkers University of California - Davis Health
Decisional Regret After Radical Cystectomy: Patient-Reported Bladder Cancer Insights from ASCO 2026 Cancer Nursing Today
10x Genomics (TXG) Launches Cleveland Clinic Partnership For Bladder Cancer Diagnostics simplywall.st
Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial Nature
Perioperative Imfinzi plus neoadjuvant EV showed statistically significant and clinically meaningful improvements in event-free survival and overall survival in muscle-invasive bladder cancer in the Phase III VOLGA trial AstraZeneca
Advancing Bladder Cancer Care Through Education and Awareness OncLive
Dr Galsky on the Current Roles of Biomarkers in Bladder Cancer OncLive
Novel ADC Combo Shows Efficacy in Phase 2 Bladder Cancer Data Oncology News Central
Body Size Linked to Higher Bladder Cancer Risk in Men: Study Medical Dialogues
An advanced in vitro bladder cancer model integrating bladder cancer spheroids into a healthy human urothelium for preclinical therapeutic testing Nature